Skip to content

Effects of Ciprofol versus Remimazolam on Hemodynamics During Anesthesia Induction in Elderly Hypertensive Patients Undergoing Elective Non-Cardiac Surgery: A Randomized, Controlled, Double-Blind Trial

Effects of Ciprofol versus Remimazolam on Hemodynamics During Anesthesia Induction in Elderly Hypertensive Patients Undergoing Elective Non-Cardiac Surgery: A Randomized, Controlled, Double-Blind Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600116317
Enrollment
Unknown
Registered
2026-01-08
Start date
2026-01-12
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Interventions

Remazolam tosylate Group (Group R):Anesthesia induction with remazolam tosylate
Ciprofol Group (Group C):Anesthesia induction with ciprofol

Sponsors

Affiliated Hospital of Guizhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Hypertensive patients aged >=65 years; 2. Classified as American Society of Anesthesiologists (ASA) physical status I to III; 3. plan to undergo elective non-cardiac surgery; 4.Provided written informed consent by either the patient or their legal guardian.

Exclusion criteria

Exclusion criteria: 1. Severe cardiovascular or pulmonary diseases; 2. Uncontrolled or poorly controlled hypertension; 3. Hepatic or renal insufficiency; 4. Neurocognitive or psychiatric disorders; 5. Known allergies or contraindications to benzodiazepines, opioids, or ciprofol; 6. History of alcohol abuse, benzodiazepine, or opioid addiction; 7. Patients with potential difficult airways.

Design outcomes

Primary

MeasureTime frame
MAP change value during induction of general anesthesia;HR change value during induction of general anesthesia;

Secondary

MeasureTime frame
Use of vasoactive drugs;Incidence of cardiovascular adverse events;Incidence of adverse drug reactions;Postoperative Nausea and Vomiting(PONV);Quality of Recovery Score(QoR-15);

Countries

China

Contacts

Public ContactMi Chen

Affiliated Hospital of Guizhou Medical University

147459443@qq.com+86 139 8408 3222

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026